Pharma Funded FDA’s Christmas Present to Drug Companies: Approving use of deadly antipsychotic drugs for kids

Many states have sued over the cost of atypical antipsychotic drugs, especially the cost of treating the diabetes and metabolic disorders they cause, which has decimated Medicaid budgets. Yet now the FDA gives pharma the Christmas present of approving Seroquel and Zyprexa for children and hence, Medicaid reimbursement even as its own Division of Pharmacovigilance (DPV) reported a “a direct association between adverse metabolic effects of treatment with atypical antipsychotics” and children!

Like we’ve always said, there’s no science to psychiatric diagnoses/the DSM. Now, even some psychiatrists are agreeing

“No matter how DSM V will be written, it will be flawed. There is no psychiatric diagnosis which has an objective measure. At the moment, all diagnoses are clinical diagnoses, meaning they are subjective. This is a field of humility. There is a lot that we do not know. I think there should be an introduction to DSM V which clearly states that this book is a product of work groups…” – Shirah Vollmer, MD

In Santa Cruz CA, where 9% of adults have taken psych drugs, advocates launch 1st Green Mental Health Care Day

Genita Petralli, president of nonprofit Green Body and Mind, director of Patient Services at Alternative to Meds Clinic, and an author of several books, says it’s her mission to “educate all those interested in what is causing the epidemic mental health crisis of today, how to avoid it, how to get off psychiatric drugs if you are on them now, and why toxic drugs should not ever be called medicine.” To that end, Petralli launched the area’s first Green Mental Health Care Day, a day where speakers and healers came together to address the problems of psychiatric drugs and offer several alternative solutions.

Op Ed: New Year’s Resolutions for the Drug Industry for 2010

Clearly the drug industry needs New Year’s Resolutions–and to honor them better than the Corporate Integrity Agreements with the government it keeps breaking. How about: “We will stop upgrading anxiety to depression, depression to bipolar disorder and bipolar disorder to ‘treatment resistant depression’ to sell drugs. We will admit that studies are beginning to show that the reason depression is sometimes treatment resistant is because it wasn’t depression to begin with but consumer advertising.”

Cooking the Books:The statistical games behind “off-label” prescription drug use

Study patients took the anti-seizure drug Neurontin, and researchers measured tons of possible outcomes (like pain with touch, pain with cold, excessive pain with pinpricks, more than a dozen different scales for psychiatric symptoms, and so on). By random chance, if you measure enough outcomes, at least some of them will appear better after drug treatment. When the time came to report the findings, however, the researchers systematically omitted the outcomes on which the drug had no effect—and presented only the data showing benefit. That’s like dealing dozens of hands of poker to yourself but showing only the hand with good cards.